Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Oncology

Diagnostics Companion diagnostics

What Would Your Oncologist Think If…

| Roberto Salgado

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?

Inside the Lab Technology and innovation

Quick Hits

| Luke Turner

Discover the latest in pathology and laboratory medicine with this roundup of short news stories

Inside the Lab Precision medicine

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Subspecialties Biochemistry and molecular biology

A Longer Life With Liver Cancer

| Luke Turner

Targeting a pathway that promotes cancer immune evasion could prolong immunotherapy and reduce its side effects for liver cancer patients

Inside the Lab Biochemistry and molecular biology

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

Outside the Lab Guidelines and recommendations

The Blue Books are Back!

| Luke Turner

The WHO’s Classification of Tumors series is entering its fifth edition – and many accessibility improvements make the latest Blue Books the best yet

Diagnostics Precision medicine

Time, Money, and Tissue

| Jason Ramos

Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer

Diagnostics Microscopy and imaging

Taking Aim at a Moving Target

| Michael Schubert

A new imaging technique provides detailed views of tumor cells, allowing researchers to visualize the transition from precancerous to cancerous

Subspecialties Microbiology and immunology

A Meaningful Microbiome

| Michael Schubert

The microbial diversity and species distribution of the cervix may help diagnosticians determine the patients at increased risk of cervical cancer.

Diagnostics Companion diagnostics

Improving Patient Outcomes

| Eslie Dennis, Eric Walk, Ken Bloom, Mark Kockx

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register